NASDAQ:WBA
Delisted

Walgreens Boots Alliance Stock News

etoro logo Buy WBA
*Your capital is at risk
$11.98
+0 (+0%)
At Close: Nov 26, 2025
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $23, indicating a -0.69% shift from the previous trading day.
Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.
Walgreens' business demonstrated solid revenue growth over the last decade, but profitability metrics are shrinking, which raises concerns over the dividend safety. I consider dividend cut risk to be
Walgreens Boots Alliance is currently unprofitable. A decrease in U.S. smokers has affected Altria.
A short squeeze may be on at Walgreens Boots Alliance. The stock climbing today doesn't negate the challenges facing the industry today.
With the equities sector falling flat while the cryptocurrency arena skyrockets, the difficulties associated with planning next moves help drive the bullish case for dividend-paying healthcare stocks.
Over the past four years, investors have become very familiar with stock market volatility. Wild swings in the S&P 500 have been the norm as the index swung from bull to bear market and back again.
The Walgreens Boots Alliance stock price has been in decline since 2015. The current price of under $21 is almost the lowest level since 2008. Walgreens Boots Alliance still faces challenges such as h
This huge drugstore chain is a safe retail play for investors looking to add health care now and trades at a very cheap 7.5 times 2023 earnings expectations.
the recent WBA share price of $20.79 represents a price-to-book ratio of 0.9 and an annual dividend yield of 9.2%
Walgreens Boots Alliance (WBA) reachead $20.79 at the closing of the latest trading day, reflecting no change compared to its last close.
"The Dow [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration.”

2 Dividend Aristocrats To Avoid

05:04am, Monday, 04'th Dec 2023
High-yield Dividend Aristocrats have underperformed the market this year, with the SPDR S&P Dividend ETF down over 3%. Dividend growth strategies offer benefits such as compounding reinvested dividend
High-dividend-yield stocks are often very risky, and they might not even pay out. Walgreens Boots Alliance is struggling to diversify during a financial crunch.

Walgreens Boots Alliance Stock: Bear vs. Bull

09:45am, Saturday, 02'nd Dec 2023
Walgreens looks to be a big player in healthcare as it launches primary and virtual care services. However, the company is struggling with profitability and already spending a lot on its dividend.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE